| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 仰佳佳 | 申万宏源 | 医药生物 | 29.62% | 33.53% | 34.79% | 16.67% | 4 | -37.64% | 2025-04-14 |
| 2 | 阳景 | 浦银国际证券 | 医药生物 | 29.62% | 38.77% | 8.01% | 100.00% | 4 | 0.00% | 2025-06-05 |
| 3 | 吴春红 | 江海证券 | 医药生物 | 29.61% | 14.58% | 13.48% | 27.27% | 7 | -25.67% | 2025-06-13 |
| 4 | 仰佳佳 | 申万宏源 | 医药生物 | 29.53% | 32.43% | 27.73% | 16.67% | 1 | -37.64% | 2025-05-09 |
| 5 | 万鹏辉 | 国海证券 | 医药生物 | 29.51% | 12.82% | 23.19% | 100.00% | 5 | 0.00% | 2025-06-09 |
| 6 | 胡晨曦 | 长城国瑞证券 | 医药生物 | 29.50% | 58.48% | 26.19% | 3.45% | 1 | -27.10% | 2025-03-19 |
| 7 | 袁聪敏 | 中信证券 | 医药生物 | 29.49% | 23.23% | 26.90% | 33.33% | 5 | -2.06% | 2025-04-15 |
| 8 | 吴春红 | 江海证券 | 医药生物 | 29.46% | 19.01% | 27.12% | 27.27% | 11 | -25.67% | 2025-04-21 |
| 9 | 阳景 | 浦银国际证券 | 医药生物 | 29.43% | 36.55% | 3.71% | 100.00% | 4 | 0.00% | 2025-05-21 |
| 10 | 阳景 | 浦银国际证券 | 医药生物 | 29.34% | 35.50% | 34.17% | 100.00% | 3 | 0.00% | 2025-04-02 |
| 11 | 仰佳佳 | 申万宏源 | 医药生物 | 29.33% | 27.73% | 13.17% | 16.67% | 1 | -37.64% | 2025-06-30 |
| 12 | 华挺 | 财通证券 | 医药生物 | 29.32% | 32.47% | 11.58% | -6.67% | 6 | -50.33% | 2025-07-09 |
| 13 | 韩盟盟 | 平安证券 | 医药生物 | 29.30% | 31.43% | 27.21% | -15.79% | 1 | -40.52% | 2025-07-11 |
| 14 | 吴春红 | 江海证券 | 医药生物 | 29.30% | 31.28% | 9.51% | 27.27% | 5 | -25.67% | 2025-07-03 |
| 15 | 武煜 | 招银国际 | 医药生物 | 29.29% | 30.91% | 16.42% | 0.00% | 2 | -6.92% | 2025-05-28 |
| 16 | 华挺 | 财通证券 | 医药生物 | 29.28% | 31.65% | 13.91% | -6.67% | 6 | -50.33% | 2025-07-07 |
| 17 | 仰佳佳 | 申万宏源 | 医药生物 | 29.27% | 35.86% | 36.09% | 16.67% | 4 | -37.64% | 2025-04-15 |
| 18 | 华挺 | 财通证券 | 医药生物 | 29.25% | 32.26% | 13.04% | -6.67% | 6 | -50.33% | 2025-07-08 |
| 19 | 万鹏辉 | 国海证券 | 医药生物 | 29.23% | 14.05% | 25.42% | 100.00% | 5 | 0.00% | 2025-06-12 |
| 20 | 韩世通 | 中信证券 | 医药生物 | 29.21% | 17.55% | 16.66% | -8.70% | 3 | -63.25% | 2025-06-12 |